Slides
Innovative immunotherapy for hypercholesterolaemiaPCSK9 as a therapeutic target to reduce LDL-C and the burden of ASCVDUnmet clinical needs in lipid lowering: Focus on LDL-CInclisiran and the ORION clinical development programPCSK9 inhibition: an overview of therapeutic approachesView all slides »Videos
Lerodalcibep: What does LIBerate-HeFH tell us?
Verve-101: Where are we up to with PCSK9 gene editing?
Apo(a) size and PAD revascularisation outcomes: What’s the link?
Lepodisiran: What progress towards Lp(a) reduction?
View all videos »Events
American College of Cardiology Scientific Sessions 2025
Event start date: 29 Mar 2025
Chicago, USA
93rd European Atherosclerosis Society Congress 2025
Event start date: 4 May 2025
Glasgow, UK
European Society of Cardiology Congress 2025 with World Congress of Cardiology
Event start date: 29 Aug 2025
Madrid, Spain, and online
View all events »
Event start date: 29 Mar 2025
Chicago, USA
93rd European Atherosclerosis Society Congress 2025
Event start date: 4 May 2025
Glasgow, UK
European Society of Cardiology Congress 2025 with World Congress of Cardiology
Event start date: 29 Aug 2025
Madrid, Spain, and online
View all events »